Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”A primary objective of Plasma Protein Therapeutics Association (PPTA) time in India was to learn more about the growing number of companies manufacturing plasma-derived medicines for the patients who rely on them.
Our first stop on this leg of the journey was at Intas Pharmaceuticals in Ahmedabad, also known as Accord Healthcare outside of India.
The organization is expanding its fractionation capacity and global footprint.
Thank you Binish Chudgar, Ritesh Saraf and Suma Ray for sharing your vision of the company’s growth trajectory.
Then we were off to biotech hub Hyderabad, where we toured the manufacturing facility of Hetero Plasma; Dr Ashok Kumar Nuvula outlied the various steps in the fractionation process utilized to ensure safety and quality, as well as Hetero‘s expansion plans for the future.
On our final day, Joshua Penrod, Dr. Ranjeet Ajmani and I were able to fit in visits with two additional organizations: Promea Therapeutics (thank you to Dr. Rajesh Tummuru and Murali Tummuru); as well as Ichor Biologics, where Anand Sudini, Pranay Reddy Sudini and Ch. Mao Manohar expressed their enthusiasm to collaborate with PPTA and the global plasma community.
As our association continues to grow and evolve… new connections and partnerships in India will play a critical role in advancing our shared mission to serve more patients around the world.”
Stay updated with Hemostasis Today.
-
Jun 29, 2026, 06:48Christina Pohlman: Anticoagulants and Bone Health – APS Awareness Month Day 23
-
Jun 29, 2026, 06:33Andreas Calatzis: Can Fibrinolysis Sensitivity Be Claimed Without a Reference Standard
-
Jun 29, 2026, 06:25Aliaa Albadri: When a Hair Wash Leads to a Stroke Workup
-
Jun 29, 2026, 06:22Tehreen Parveen: Historical Milestone in Drug Discovery – The Discovery of Aspirin
-
Jun 29, 2026, 06:16Muhammad Sufyan: Deep Vein Thrombosis – Recognizing the Warning Signs
-
Jun 29, 2026, 05:33Janak Sadhu: Uniting for The Stroke-Free Mehsana Initiative
-
Jun 29, 2026, 05:20Deepti Sachan: A Global Exchange Shaping the Future of Transfusion Medicine at ISBT 2026
-
Jun 29, 2026, 04:50Scott Cameron: ACC/AHA Guidance on Acute Pulmonary Embolism Management
-
Jun 29, 2026, 03:10Aryabhatta Sadhu: ABO and Rh Incompatibility In Stem Cell Transplantation